Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden

BACKGROUND: People who inject drugs (PWID) represent a population with an increased prevalence of hepatitis C (HCV) infections. HCV treatment among PWID is essential to reach the WHO goal of eliminating HCV as a major public health threat by 2030. Despite better understanding of PWID subgroups and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindqvist, K., Thorin, Z., Kåberg, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258779/
https://www.ncbi.nlm.nih.gov/pubmed/37308951
http://dx.doi.org/10.1186/s12954-023-00801-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258779/
https://www.ncbi.nlm.nih.gov/pubmed/37308951
http://dx.doi.org/10.1186/s12954-023-00801-1

Ejemplares similares